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Abstract
Background: The Apgar score has been shown to be predictive of neonatal mortality in clinical and population
studies, but has not been used for international comparisons. We examined population-level distributions in
Apgar scores and associations with neonatal mortality in Europe.
Methods: Aggregate data on the 5 minute Apgar score for live births and neonatal mortality rates from countries
participating in the Euro-Peristat project in 2004 and 2010 were analysed. Country level associations between the
Apgar score and neonatal mortality were assessed using the Spearman rank correlation coefficient.
Results: Twenty-three countries or regions provided data on Apgar at 5 minutes, covering 2 183 472 live births.
Scores <7 ranged from 0.3% to 2.4% across countries in 2004 and 2010 and were correlated over time (q = 0.88,
P < 0.01). There were large differences in healthy baby scores: scores of 10 ranged from 8.8% to 92.7% whereas scores
of 9 or 10 ranged from 72.9% to 96.8%. Countries more likely to score 10 s, as opposed to 9 s, for healthy babies had
lower proportions of Apgar <7 (q = 0.43, P = 0.04). Neonatal mortality rates were weakly correlated with Apgar
score <7 (q = 0.06, P = 0.61), but differences over time in these two indicators were correlated (q =0.56, P = 0.02).
Conclusions: Large variations in the distribution of Apgar scores likely due to national scoring practices make the
Apgar score an unsuitable indicator for benchmarking newborn health across countries. However, country-level
trends over time in the Apgar score may reflect real changes and merit further investigation.
Keywords: Apgar Score, neonatal morbidity, neonatal mortality, health indicators.
Since its introduction in 1952, the Apgar score has
been used worldwide for the rapid and standardised
assessment of neonates after delivery to determine
the need for prompt resuscitative intervention.1,2
The Apgar score consists of five clinical signs which
are each given a score of 0, 1, or 2 (Table S1). The
overall Apgar score is the sum of these components
and is defined as reassuring for a score of 7–10,
moderately abnormal for a score of 4–6, and low for
a score of 0–3.3 The score is reported at 1 and
5 minutes after birth for all neonates, and subse-
quently at five-minute intervals until 20 minutes
after birth for neonates with a non-reassuring score.
Over half a century since the Apgar score became
integrated in routine clinical practice, it remains a
standardised, effective, and convenient tool for
neonatal assessment.4–6
Although the Apgar score was never intended for
the prediction of mortality or long-term disability, its
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utility beyond triage for immediate resuscitation is of
significant interest. A low Apgar score at 1 minute
can often be the result of a transient depression in the
component parameters and has not been shown to be
associated with clinical outcomes.7 A low or moder-
ately abnormal 5 minute Apgar score is, however, of
greater predictive value, as evidenced by its correla-
tion with neonatal mortality in large population and
clinical studies.5–10 A non-reassuring 5 minute Apgar
score has also been shown to be predictive of infant
mortality.8,10,11 Furthermore, large national registry
studies with long-term follow up indicate an associa-
tion of a 5 minute Apgar score less than 7 with neuro-
logical and developmental disabilities later in life,
such as cerebral palsy,9,10 epilepsy,10 mental retarda-
tion,10,12 and lower academic achievement in sec-
ondary school.13 Created for the assessment of term
neonates, the physiological applicability of Apgar
scores in preterm births is questioned since immatu-
rity itself results in lower scores in the absence of
neonatal distress.14 However, population studies sug-
gest that low Apgar scores are equally prognostic of
mortality in preterm neonates.8,11,15
The aforementioned studies suggest that, despite
significant advances in perinatal care and neonatology
since the Apgar score was introduced, it remains not
only a relevant tool in the clinical management of
neonates, but is also associated with mortality and
morbidity at the population level. An analysis of pop-
ulation level trends in Apgar scores may therefore
potentially serve as an internationally comparative
indicator reflecting the burden of mortality and mor-
bidity. While neonatal mortality is a key indicator of
newborn health, its low incidence – under 2 per 1000
live births in many countries in Europe and under 3
per 1000 live births in the majority of European coun-
tries16 – may reduce its usefulness for monitoring out-
comes, in particular for sub-populations with a fewer
number of births. The Apgar score is routinely col-
lected by many European national health systems and
could add to the tool kit for evaluating obstetrical and
early neonatal quality of care. To our knowledge esti-
mates of national aggregate Apgar scores have not
previously been tested towards such an application.
We examined population level rates and trends in
Apgar scores to determine if they relate to neonatal
mortality in European cross-country comparisons.
Evidence suggests that there is significant inter-
observer variability in the 5 minute Apgar score,17–20
possibly due to its subjective components. Therefore,
we also tested for differences between countries in the
distribution of extreme and intermediate Apgar
scores, to determine if norms vary nationally.
Methods
Data for this study were collected by the Euro-Peristat
project which is an EU-funded network of clinicians,
statisticians, and researchers from EU Member States,
Norway, Iceland, and Switzerland. Scientific Commit-
tee members in each participating country are respon-
sible for the data collection of 10 core and 20
recommended indicators essential for the surveillance
of perinatal health. We used data collected on births
in 2004 and 2010, published as part of the European
Perinatal Health Reports.21,22 Full details of the Euro-
Peristat indicators are available on the Euro-Peristat
website.23,24
The Euro-Peristat indicators are compiled from
aggregated data provided from routine data
sources.23,24 In most countries, perinatal health data
were held in vital statistics, civil registers, and medi-
cal birth registers but data also came from nationally
representative surveys of births in Cyprus and in
France. Data were required to be population-based
and should cover the whole country, but if countries
could not provide information at the national-level,
regional data were also accepted. For example, data
for Belgium were provided separately from the
regions of Brussels, Wallonia and Flanders, and data
from the United Kingdom were provided separately
by the UK’s constituent countries: England and Wales
combined, Northern Ireland, and Scotland. Finally,
some countries could not provide data for the years
requested, and data from the most recent year avail-
able were accepted. Data from Cyprus were from 2007
instead of 2010, France provided data from 2003
instead of 2004, and England and Wales provided
neonatal mortality data from 2005 instead of 2004.
Data were collected on all births and deaths at or
after 22 weeks; the 22-week gestational age threshold
is recommended by Euro-Peristat for the collection of
all data on births in Europe.24 Gestational age was
defined as the best obstetric estimate. When gesta-
tional age was missing, we asked countries to include
births if birth weight was 500 grams or more.
We used data from two indicators: the distribution
of the 5 minute Apgar score and the neonatal mortal-
ity rate. We calculated percentages of live births with
an Apgar score <4, 4–6 7–10. The neonatal mortality
© 2017 John Wiley & Sons Ltd
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rate is defined as the number of neonatal deaths (day
0 through 27) after live birth and expressed per 1000
live births. Indicators from 2004 and 2010 were used.
For this ecological study, the unit of inference was
the country. We first described the distributions of
Apgar at 5 minutes across countries and examined
the association of low Apgar scores across the two
time periods to assess consistency and changes over
time. We then correlated the proportions of low
Apgar scores (<7), and very high Apgar scores of 9 or
10 across countries in order to assess whether coding
practices for healthy infants affected the classification
of high risk infants. To measure differences in coding
practices we computed the proportion of neonates
with a score of 10 among those with scores of 9 or 10
to measure the tendency to score more highly, inde-
pendent of the Apgar score distribution overall. To
investigate the association with neonatal mortality,
we correlated low scores with neonatal mortality in
2004 and 2010, and studied temporal trends by assess-
ing correlations between rate differences in the Apgar
score and neonatal mortality between 2004 and 2010.
Spearman’s non-parametric correlation was used
for all analyses. While the focus was on low Apgar
scores <7, we also assessed other clinically meaningful
cut-offs: <4, representing the most critically abnormal
scores and <9, representing anything besides com-
pletely healthy babies. To take into consideration dif-
ferences in country population size, we integrated
data on annual volume of births into graphical pre-
sentations to illustrate how countries with small num-
bers of annual births might affect the observed
associations. However, we did not weight for country
size as the country was our observation. Weighting by
population size would effectively change the infer-
ence away from the ecological towards a study of the
total population of the included countries. We also
carried out sensitivity analyses by removing countries
with low population sizes.
There were less than 3% missing data on the Apgar
score in participating countries in 2004 and 2010.
Exceptions included Finland (missing 19% in 2004
and 15% in 2010) and Wales (missing 22% in 2004 and
8% in 2010). For Finland, most children missing data
at 5 minute had Apgar scores at 1 minute, since
5 minute scores may remain unrecorded if the
1 minute scores are high. For these births, we
assigned the mean value at 5 minute corresponding
to 1 minute Apgar scores as observed in the sample
with non-missing values. Other missing data were
excluded from the analyses. All analyses were per-
formed using Stata, V.14.0 SE (Stata Corporation, Col-
lege Station, Texas, USA).
Results
Twenty-three countries or regions covering a total of
2 192 632 live births provided data on Apgar scores in
2010, of which 6550 or 0.3% had scores under 4 with a
range from 0.1% to 0.7% and a further 17 468 or 0.8%
between 4 and 6, with a range from 0.2% to 1.7%
(Table 1). The percent of all Apgar scores <7 across
countries ranged between 0.3–2.4%. Overall 93.2% of
reported live births received Apgar scores of 9 or 10
with a range from 72.9% to 96.8%. Within this group
there were large variations in the scoring of 9s vs. 10s.
For example, in France 92.7% of the scores were 10
and only 3.9% were 9, whereas in Scotland 18.7% of
scores were 10 and 76.3% were 9. Certain countries
were outliers across the range of scores, most notably
Estonia, Iceland, and Latvia. Apgar score distributions
for 2004 are presented in Table S2.
Apgar scores <7 in 2010 were highly correlated with
scores <7 in 2004, as shown in Figure 1 (q = 0.88,
P < 0.01). Scores of 10 ranged from 4% to 88% of total
scores 9 and 10. Countries that were more likely to
assign 10 had a lower prevalence of Apgar scores <7
in 2010 (Spearman’s rho = 0.43, P = 0.04, 23 coun-
tries). A negative correlation was observed in 2004,
but it was not statistically significant (Spearman’s
rho = 0.38, P = 0.10, 20 countries).
Neonatal mortality rates across countries were not
associated with the proportion of abnormal Apgar
scores <7 for both study years investigated (Figure 2)
nor were they correlated with scores <4 (2010:
q = 0.05, P = 0.83, 22 countries; 2004: q = 0.16,
P = 0.52, 19 countries) or scores <9 (2010: q = 0.02,
P = 0.94, 22 countries; 2004: q = 0.20, P = 0.41, 19
countries). These correlations were not affected by
sensitivity analyses which involved removing the
countries with smallest sample sizes (Iceland, Malta,
and Luxembourg). Data on the number of neonatal
deaths and mortality rates in 2004 and 2010 are
presented in Table S3.
In countries with data on Apgar scores and neonatal
mortality in both 2004 and 2010, the average decrease in
neonatal mortality was 23% (an average rate difference
of 0.77 per 1000), whereas Apgar scores <7 increased
slightly by 2.8% (a rate difference of 0.14). Rate differ-
ences in the Apgar score <7 between these two periods
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were positively correlated with mortality rate differ-
ences (Figure 3). In sensitivity analyses removing the
two smallest countries (Malta and Luxembourg) the
estimation of the correlation coefficient remained posi-
tive, but the significance level declined (q=0.44, P = 0.09,
16 countries). The difference in the neonatal mortality
rate was similarly correlated with rate differences in the
proportions of Apgar scores <4 (q = 0.46, P = 0.06,
N = 18) and <9 (q = 0.51, P = 0.03, 18 countries).
Comment
Principal ﬁndings
There were wide variations in the prevalence of new-
borns with low 5 minute Apgar score <7 across Euro-
pean countries, but our results suggest that some of
this variability reflects heterogeneity in clinical
scoring practices as opposed to true differences in
biomedical outcomes. While there was no correlation
between neonatal mortality rates and low Apgar
scores in both years included in this study, changes at
the country-level in proportions of newborns with
low Apgar scores over time were associated with
changes in neonatal mortality rates.
Strengths and limitations
This investigation had several strengths. We included
data covering a broad geographical area representa-
tive of all regions of Europe. Data were collected for
the same years using consistent data sources within
countries. In addition, common data collection proto-
cols and definitions of indicators (i.e. Apgar score and
neonatal mortality rate) were employed. The use of
aggregate data was a limitation of the study as it
Table 1. Distribution of Apgar scores at 5 minute by country in 2010
Country Code Total live birthsa N
5-minute Apgar score
<7 ≥7
<4% 4–6% All <7% 7% 8% 9% 10%
Austria AT 78 609 0.2 0.6 0.8 0.8 3.2 12.0 83.2
BEb: Brussels BE:BR 24 742 0.2 1.4 1.6 2.0 5.1 16.9 74.5
BEb: Flanders BE:FL 69 575 0.3 1.3 1.5 1.9 6.1 37.2 53.2
BEb: Wallonia BE:WA 38 083 0.3 1.2 1.4 1.8 5.1 20.7 71.0
CypruS CY 8529 0.1 0.4 0.5 1.3 4.3 13.4 80.6
Czech Republic CZ 116 399 0.2 0.8 1.0 1.1 3.5 14.4 80.0
Denmark DK 62 902 0.3 0.6 0.8 0.6 1.7 4.7 92.1
Estonia EE 15 774 0.2 1.0 1.2 2.6 16.5 62.2 17.6
Finlandc FI 61 080 0.4 1.7 2.1 2.1 6.6 66.4 22.8
France FR 14 602 0.2 0.6 0.8 0.8 1.7 3.9 92.7
Germany DE 632 780 0.2 0.8 1.0 1.3 4.4 16.4 77.0
Iceland IS 4903 0.7 1.7 2.4 3.0 8.3 32.3 54.1
Italy IT 538 177 0.3 0.5 0.8 0.8 5.0 31.8 61.6
Latvia LV 19 043 0.2 1.4 1.6 4.6 20.9 64.1 8.8
Lithuania LT 30 763 0.1 0.2 0.3 0.6 6.4 33.8 58.9
Luxembourg LU 6493 0.1 0.8 0.9 1.0 4.4 15.8 77.9
Malta MT 4013 0.2 0.7 0.9 0.7 1.7 82.7 14.0
Netherlands NL 177 649 0.4 1.2 1.6 1.4 4.0 17.1 76.0
Norway NO 62 345 0.4 1.0 1.4 1.2 3.9 31.9 61.6
Slovenia SI 22 292 0.2 0.7 0.9 0.8 3.7 59.5 35.1
Sweden SE 113 950 0.3 1.0 1.3 1.1 2.4 10.2 85.0
UK: Scotland UK:S 56 756 0.5 1.0 1.5 0.9 2.6 76.3 18.7
UK: Wales UK:W 33 173 0.3 1.0 1.2 0.9 2.4 43.9 51.6
All countries 2 192 632 0.3 0.8 1.1 1.2 4.5 25.3 67.9
aFor which Apgar stated.
bRegion of Belgium; note data from Brussels includes women delivering in maternity units in Brussels and includes some women trans-
ferred into hospitals from outside the region.
cMissing data at 5 minute imputed from data at 1 minute (see methods).
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prevented the ability to explore medical and social
covariates of interest or allow for more detailed statis-
tical analyses within subgroups, for instance, assess-
ing mortality rates by individual 5 minute Apgar
scores or analysing Apgar scores by gestational age
week. We were not able to identify cause-specific mor-
tality which may be linked to the Apgar score, such as
asphyxia or deaths due to very preterm birth. Another
potential limitation was differences in data sources
between countries which could lead to differences in
data quality or other parameters.
Comparison with other studies and interpretation
The range of European 5 minute Apgar scores <7 iden-
tified in this study is consistent with those from other
developed countries for which national data are avail-
able. In Australia, approximately 0.9% of all scores were
less than 7 during 2004–09, however, the rates were
higher than the national average among indigenous
populations (1.4%) and babies delivered in public hos-
pitals (1.1%).25 In the United States, the overall propor-
tion of scores less than 7 was 1.9% in 2012, however, the
Figure 1. Correlation of proportions of
low Apgar scores <7 in 2004 and 2010
NOTES: red circles proportional to
annual number of births within each
country; Spearman’s rho 0.88 (p≤0.01),
n=19.
Figure 2. Correlation of Neonatal
Mortality Rates with Proportions of
Apgar Scores <7 in 2010. NOTES:
*Neonatal deaths per 1,000 live births;
red circles proportional to annual
number of births within each country;
Spearman’s rho: 0.06 (p=0.78), N=22.
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percentage was notably higher for Black babies
(3.2%).26
Unlike our findings, prior clinical research as well
as population based studies using routinely collected
data found strong associations between neonatal
mortality and low Apgar scores.6–11,27 However, our
study differed from these previous analyses in that
it used cross-national ecological correlations of low
Apgar scores and neonatal mortality rates. We
hypothesise that some of the observed variation in
Apgar scores reflect country-specific variations in
scoring practices which may be a result of clinical
training or convention. To investigate the effect of
coding, we examined the more frequent use of a
score of 10 as opposed to 9 for healthy babies
(coded 9 or 10), which we considered to primarily
reflect scoring practices because of the very large
differences observed across countries in the attribu-
tion of the scores 10 vs. 9. The fact that a higher
proportion of 10s was correlated with low scores
suggests that scoring differences for healthy babies
may cause a shift across the whole distribution and
less stringent application of the score to high risk
babies. Some of the variation in the prevalence of 9
vs. 10 scores could also reflect real differences
between countries; one Canadian study found
higher risk of developmental vulnerability at 5 years
of age among the 82% of babies with an Apgar score
of 9 vs. the 6% with an Apgar score of 10.28 How-
ever, our study illustrates that findings such as these
must be translated with caution into other contexts,
as we observed a range from 9% to 93% in scores of
10. The subjective nature of the Apgar score’s vari-
ous components as well as differences in clinical
conditions, such as resuscitation, have previously
been posited as reasons for inter-observer variability
within countries.17–20
We could not take into consideration the effect of
early neonatal interventions such as resuscitation and
mechanical ventilation. The uncertainty of assigning
Apgar scores in these circumstances could be one of
the reasons for the differences in cross-national scor-
ing. ‘Expanded’ or ‘combined’ Apgar scores with
additional objective clinical components describing
resuscitative measures have been proposed which
may be better suited to modern healthcare set-
tings.4,14,29,30 These have been shown in some
instances to be superior in predicting outcomes as
compared to the traditional Apgar score.31
While these results call into question the external
validity of the Apgar score for comparing the preva-
lence of high risk newborns at birth across countries,
we found correlations between changes in Apgar
scores and neonatal mortality over time. By using rate
differences, country specific errors in measurement of
indicators would be minimised. These results suggest
that this indicator could provide useful information
about national trends in newborn health, however,
they should be replicated using more complete time
series data and more countries.
Figure 3. Correlation of Neonatal
Mortality Rate Differences with
Differences in Percent of Apgar Scores
<7 in 2010 and 2004. NOTES: red circles
proportional to annual number of births
within each country; Spearman’s rho:
0.56 (p=0.02), N=19.
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Implications for future research, policy, and practice
This study suggests that comparisons of Apgar scores
across countries should not be undertaken without
first assessing the external validity of this indicator.
Despite the existence of a common definition and
established guidelines for assigning Apgar scores, its
translation into practice was highly heterogeneous
across countries. Although there is wide agreement
on the <7 threshold for defining low scores, this
threshold would potentially select different subsets of
children depending on a specific country’s coding
practices. Higher thresholds may be even more vul-
nerable to variations in scoring practices, as shown by
large differences in the prevalence of newborns with
Apgar scores of 9 vs. 10. However, integrating more
information on delivery, cause-specific mortality, ges-
tational age, as well as early neonatal interventions
could make it possible to improve post hoc standardi-
sation of the scoring system across different contexts
by, for instance, comparing Apgar scores among term
infants or taking into consideration the proportion of
infants who are ventilated.
More generally, this study highlights the difficulty
of conducting valid cross-national comparisons of
health and the importance of examining the external
validity of indicators used for these comparisons. This
may be true for other health indicators which pre-
sume a common definition and shows the need for
research to validate indicators used to benchmark
health and care internationally.
Conclusion
Internationally comparative perinatal health indica-
tors make it possible to assess differences in prac-
tices and outcomes and to assess interventions
towards the creation of best practices. However,
while the Apgar score is available in many routine
databases and may have good internal validity, as
shown by many previous studies linking it to peri-
natal and child health outcomes, our analysis sug-
gests that the external validity in cross-national
comparisons is limited. These results do not sup-
port the use of the Apgar score to benchmark new-
born health across countries without more work to
standardise coding and reporting; however, moni-
toring trends over time in Apgar scores could pro-
vide additional information about newborn health
and quality of obstetrical and early neonatal care.
Further research, integrating additional information
on pregnancy and newborn characteristics and
interventions would be useful to confirm these
findings.
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